Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia.
| Autor: | Kamal HI; Internal Medicine, Ascension Providence Hospital, Southfield, USA., Patel K; Internal Medicine, Ascension Providence Hospital, Southfield, USA., Brdak A; Internal Medicine, Ascension Providence Hospital, Novi, USA., Heffernan J; Internal Medicine, Ascension Providence Hospital, Southfield, USA., Ahmad N; Endocrinology, Diabetes and Metabolism, Ascension Providence Hospital, Southfield, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2022 Mar 25; Vol. 14 (3), pp. e23494. Date of Electronic Publication: 2022 Mar 25 (Print Publication: 2022). |
| DOI: | 10.7759/cureus.23494 |
| Abstrakt: | Ashwagandha root extract (ARE) is a reputed herbal supplement in Ayurvedic medicine for a variety of health conditions. To date, scant attention has been paid to thyrotoxicosis associated with Ashwagandha and it is rarely reported in the literature. We report a 73-year-old female who presented with supraventricular tachycardia, symptoms of hyperthyroidism and significantly low TSH levels, after two years of using ARE as a self-administered treatment for hypothyroidism. Full symptomatic resolution and biochemical improvement ensued upon cessation of the supplement. Though the pathophysiology remains obscure, we hope to promote awareness concerning this rare yet possible side effect of Ashwagandha. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Kamal et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|